Search

Igen International Inc. entered a $60 million, 28-month equity financing facility with Acqua Wellington North American Equities Fund Ltd. that called for an Initial equity financing totaling $3 million. Igen, [...]

Igen International Inc. filed a shelf registration statement with the U.S. Securities and Exchange Commission that will give the company authority, at its discretion, to sell up to 3 million [...]

With a lead cancer product targeting the epidermal growth factor receptor, ImClone Systems Inc. is making a move designed to boost the firm's own growth factor filing a shelf registration [...]

NeoPharm Inc. is seeking to raise more than $55 million in its first public offering since moving from the Amex to the Nasdaq exchange in April. The 2.8-million-share offering would [...]

BioWorld Stock Report For Public Biotechnology Companies Close Close % Change Company Symbol 4/20 4/28 WK YTD Aastrom Biosci ASTM 3.156 2.875 -8.90 268.12 Abgenix ABGX 82.5 89.563 8.56 35.19 [...]

Quidel (San Diego), a provider of point-of-care rapid diagnostic tests, said its board of directors has authorized the company to repurchase up to an additional $25 million in shares of [...]

Despite a market cap of close to $3 billion and a 58 percent increase in Erbitux revenues in 2005, ImClone Systems Inc. is exploring strategic options that could include the [...]

AMDL (Tustin, California), a developer of tests for the early detection of cancer and other serious diseases, reported that it has conducted the second closing of a combined Regulation D/Regulation [...]

ImClone System Inc.'s stock jumped more than 14 percent on confirmation from independent reviewers that Erbitux, the company's once scandal-ridden colorectal cancer drug, worked in a Phase III study as [...]

Stock values plummeted in the companies behind the molecular imaging agent Combidex (ferumoxtran-10) following a negative FDA panel vote. That thumbs-down damaged Cambridge, Mass-based Advanced Magnetics Inc.'s shares by two-thirds [...]

ImClone Systems Inc.'s stock fell 18.9 percent July 21 even though the firm turned a profit on Erbitux sales and said it intends to request FDA approval of the drug [...]

ImClone Systems Inc.'s decline in value hours before the FDA released a statement saying it had approved Erbitux may have raised a few eyebrows, but so far it's unclear whether [...]

* Spectral Diagnostics (Toronto, Ontario) and a group of investors led by the Canadian Medical Discoveries Fund (CMDF) entered into agreements, effective Dec. 31, that establish a joint-venture company, IDx [...]

* Ikonisys (New Haven, Connecticut), a developer of cell-based diagnostic products for the obstetrical and oncology markets, said a group of private investors led by Saint Simeon Marketing e Investimentos [...]

Matritech (Newton, Massachusetts), a developer of proteomics-based diagnostic products, said it has closed a $6 million private placement for the sale of 3.59 million shares of its common stock and [...]

Apogent Technologies (Portsmouth, New Hampshire) reported receiving the requisite consents to execute a supplemental indenture amending the indenture relating to its 8% senior notes, due 2011, pursuant to the previously [...]

AMD (Tustin, California), developer and marketer of tests for the early detection of cancer and other serious diseases has completed a Regulation S private offering, which began in August. The [...]

* Apogent Technologies (Portsmouth, New Hampshire) said that it has closed its previously announced private placement of $250 million of 6 1/2% senior subordinated notes due 2013. Apogent's obligations are [...]

* Matritech (Newton, Massachusetts), a developer of proteomics-based diagnostic products, reported closing the sale of $5 million of 7.5% convertible debentures and warrants to purchase 784,314 shares of common stock [...]

Samuel Waksal, former CEO of New York-based ImClone Systems Inc., could face up to 65 years in prison and millions of dollars in fines on bank fraud and insider trading [...]

In the latest episode of an ongoing saga. ImClone Systems Inc. gained and lost in a retooling of what had been touted as a landmark potential $2 billion deal with [...]